Orally Disintegrating Selegiline

Orally disintegrating selegiline is a medication approved to treat symptoms associated with Parkinson's disease. This prescription medication can only be used in combination with carbidopa-levodopa medications. Before taking orally disintegrating selegiline, make sure your healthcare provider is aware of all other medical conditions you have and any other medications you are taking (including vitamins and supplements).

Selegiline for Parkinson's Disease

What Is Orally Disintegrating Selegiline?

Orally disintegrating selegiline (Zelapar^®) is a prescription medication licensed to treat Parkinson's disease. It is approved for use in combination with carbidopa-levodopa medications (such as Sinemet^®, Sinemet CR^®, or Parcopa^®). Because orally disintegrating selegiline tablets dissolve rapidly on the tongue without any need for water, they are especially useful for people who have difficulty swallowing tablets.

(Click What Is Orally Disintegrating Selegiline Used For? for more information, including possible off-label uses.)

Orally Disintegrating Selegiline Side Effects

As with any medicine, side effects are possible with orally disintegrating selegiline. Although some side effects may be merely bothersome, some are quite serious or intolerable. Side effects often limit the usefulness of the drug.

Common side effects of orally disintegrating selegiline include but are not limited to:

Dizziness
Nausea
Pain
Insomnia.

(Click Side Effects of Orally Disintegrating Selegiline to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)

(Orally Disintegrating Selegiline Continued: Page 2)